Department of Neuroradiology, Hospital de Braga, Braga, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Department of Epidemiology, National Alzheimer's Coordinating Center, University of Washington, Seattle, WA, USA.
Neurobiol Aging. 2022 Sep;117:1-11. doi: 10.1016/j.neurobiolaging.2022.04.013. Epub 2022 May 1.
Our study compared brain MRI with neuropathological findings in patients with primary age-related tauopathy (PART) and Alzheimer's disease (AD), while assessing the relationship between brain atrophy and clinical impairment. We analyzed 233 participants: 32 with no plaques ("definite" PART-BRAAK stage higher than 0 and CERAD 0), and 201 cases within the AD spectrum, with 25 with sparse (CERAD 1), 76 with moderate (CERAD 2), and 100 with severe (CERAD 3) degrees of neuritic plaques. Upon correcting for age, sex, and age difference at MRI and death, there were significantly higher levels of atrophy in CERAD 3 compared to CERAD 1-2 and a trend compared to PART (p = 0.06). In the anterior temporal region, there was a trend for higher levels of atrophy in PART compared to Alzheimer's disease spectrum cases with CERAD 1 (p = 0.08). We then assessed the correlation between regional brain atrophy and CDR sum of boxes score for PART and AD, and found that overall cognition deficits are directly correlated with regional atrophy in the AD continuum, but not in definite PART. We further observed correlations between regional brain atrophy with multiple neuropsychological metrics in AD, with PART showing specific correlations between language deficits and anterior temporal atrophy. Overall, these findings support PART as an independent pathologic process from AD.
我们的研究比较了原发性年龄相关性 tau 病 (PART) 和阿尔茨海默病 (AD) 患者的脑 MRI 与神经病理学发现,同时评估了脑萎缩与临床损伤之间的关系。我们分析了 233 名参与者:32 名无斑块(“明确”PART-BRAAK 分期高于 0 且 CERAD 0),201 名 AD 谱病例,25 名稀疏斑块(CERAD 1),76 名中度斑块(CERAD 2),100 名严重斑块(CERAD 3)。在校正 MRI 和死亡时的年龄、性别和年龄差异后,CERAD 3 的萎缩程度明显高于 CERAD 1-2,与 PART 相比呈趋势(p=0.06)。在前颞区,PART 与 AD 谱病例的 CERAD 1 相比,萎缩程度呈上升趋势(p=0.08)。然后,我们评估了 PART 和 AD 中区域性脑萎缩与 CDR 总评分之间的相关性,发现总体认知缺陷与 AD 连续体中的区域性萎缩直接相关,但与明确的 PART 无关。我们进一步观察了 AD 中区域性脑萎缩与多个神经心理学指标之间的相关性,PART 显示语言缺陷与前颞叶萎缩之间存在特定相关性。总体而言,这些发现支持 PART 是 AD 之外的一个独立的病理过程。